Literature DB >> 22193621

Elevated risk of hypertension induced by arsenic exposure in Taiwanese rural residents: possible effects of manganese superoxide dismutase (MnSOD) and 8-oxoguanine DNA glycosylase (OGG1) genes.

Shiuan-Chih Chen1, Chun-Chieh Chen, Chung-Yih Kuo, Chun-Huang Huang, Chin-Hsiu Lin, Zi-Yun Lu, Yi-Yu Chen, Hong-Shen Lee, Ruey-Hong Wong.   

Abstract

Heavy metals, including arsenic and lead, may lead to cellular oxidative damage that is linked to hypertension. Manganese superoxide dismutase (MnSOD) is a scavenger of reactive oxygen species, and 8-oxoguanine DNA glycosylase (OGG1) is the major glycosylase that repairs DNA lesions. Interestingly, whether there is an elevated risk of hypertension with arsenic or lead exposure in individuals with genetic variations in MnSOD or OGG1 has not yet been investigated. Questionnaires were administered to 240 Taiwanese rural residents. Blood pressure and biochemical indicators were assessed in each subject. Urinary levels of arsenic and lead were measured with atomic absorption spectrometry; and MnSOD and OGG1 genotypes were identified via polymerase chain reaction. There was a dose-response relationship between urinary arsenic levels and risk of hypertension (P = 0.021, test for trend). However, there was no association between urinary lead levels and hypertension risk. Individuals with high urinary arsenic levels and the MnSOD Val-Ala/Ala-Ala genotypes had a greater risk of hypertension than those with low urinary arsenic levels and the MnSOD Val-Val genotype (odds ratio [OR] = 4.2, 95% confidence interval [CI] = 1.7-10.3). Subjects with a high urinary arsenic level and the OGG1 Cys-Cys genotype also had a greater risk of hypertension than those with a low urinary arsenic level and the OGG1 Ser-Ser/Ser-Cys genotypes (OR = 3.4, 95% CI = 1.1-10.7). Thus, both MnSOD and OGG1 genotypes may be prone to an increased risk of hypertension associated with arsenic exposure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22193621     DOI: 10.1007/s00204-011-0797-8

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  12 in total

1.  Risk of death from cardiovascular disease associated with low-level arsenic exposure among long-term smokers in a US population-based study.

Authors:  Shohreh F Farzan; Yu Chen; Judy R Rees; M Scot Zens; Margaret R Karagas
Journal:  Toxicol Appl Pharmacol       Date:  2015-06-03       Impact factor: 4.219

Review 2.  Individual susceptibility to arsenic-induced diseases: the role of host genetics, nutritional status, and the gut microbiome.

Authors:  Liang Chi; Bei Gao; Pengcheng Tu; Chih-Wei Liu; Jingchuan Xue; Yunjia Lai; Hongyu Ru; Kun Lu
Journal:  Mamm Genome       Date:  2018-02-10       Impact factor: 2.957

Review 3.  Molecular insight of arsenic-induced carcinogenesis and its prevention.

Authors:  Paramita Mandal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-22       Impact factor: 3.000

4.  Arsenic and subclinical vascular damage in a sample of Italian young adults: a cross-sectional analysis.

Authors:  Francesco Stea; Francesco Faita; Andrea Borghini; Francesca Faita; Fabrizio Bianchi; Elisa Bustaffa; Fabrizio Minichilli; Maria Grazia Andreassi; Rosa Sicari
Journal:  Environ Sci Pollut Res Int       Date:  2016-07-23       Impact factor: 4.223

5.  Gene-arsenic interaction in longitudinal changes of blood pressure: Findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh.

Authors:  Shohreh F Farzan; Margaret R Karagas; Jieying Jiang; Fen Wu; Mengling Liu; Jonathan D Newman; Farzana Jasmine; Muhammad G Kibriya; Rachelle Paul-Brutus; Faruque Parvez; Maria Argos; Molly Scannell Bryan; Mahbub Eunus; Alauddin Ahmed; Tariqul Islam; Muhammad Rakibuz-Zaman; Rabiul Hasan; Golam Sarwar; Vesna Slavkovich; Joseph Graziano; Habibul Ahsan; Yu Chen
Journal:  Toxicol Appl Pharmacol       Date:  2015-07-26       Impact factor: 4.219

6.  Arsenic, blood pressure, and hypertension in the Strong Heart Family Study.

Authors:  John A Kaufman; Claire Mattison; Amanda M Fretts; Jason G Umans; Shelley A Cole; V Saroja Voruganti; Walter Goessler; Lyle G Best; Ying Zhang; Maria Tellez-Plaza; Ana Navas-Acien; Matthew O Gribble
Journal:  Environ Res       Date:  2021-02-11       Impact factor: 6.498

7.  Administration of zinc against arsenic-induced nephrotoxicity during gestation and lactation in rat model.

Authors:  Davood Nasiry Zarrin Ghabaee; Fereshteh Talebpour Amiri; Amir Esmaeelnejad Moghaddam; Ali Reza Khalatbary; Mehryar Zargari
Journal:  J Nephropathol       Date:  2016-12-25

8.  A prospective cohort study of stroke mortality and arsenic in drinking water in Bangladeshi adults.

Authors:  Mahfuzar Rahman; Nazmul Sohel; Mohammad Yunus; Mahbub Elahi Chowdhury; Samar Kumar Hore; Khalequ Zaman; Abbas Bhuiya; Peter Kim Streatfield
Journal:  BMC Public Health       Date:  2014-02-18       Impact factor: 3.295

Review 9.  Current developments in toxicological research on arsenic.

Authors:  Hermann M Bolt
Journal:  EXCLI J       Date:  2013-01-21       Impact factor: 4.068

10.  Improved genotyping of N-acetyltransferase 2: role of the ultra-slow acetylators.

Authors:  Meinolf Blaszkewicz
Journal:  EXCLI J       Date:  2013-12-05       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.